查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594494

次世代定序仪样品製备市场：按工作流程、应用和最终用户 - 2025-2030 年全球预测

Next-Generation Sequencing Sample Preparation Market by Workflow, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

次世代定序仪样品製备市场2023年估值为48.9亿美元，预计到2024年将达到56.3亿美元，复合年增长率为15.08%，到2030年将达到130.9亿美元。

次世代定序(NGS) 样本製备是基因测序过程的关键组成部分，涉及将天然生物样本转化为适合后续定序的核酸文库。这种製备至关重要，因为有效的样品製备可确保 NGS 技术的准确性和效率，而 NGS 技术广泛应用于基因组研究、诊断和个人化医疗。市场最终用途包括临床诊断、製药和生物技术公司、学术研究机构和农业基因组学，每个都利用 NGS 进行疾病诊断、药物发现和作物改良等各种应用。主要成长动力包括个人化医疗需求的增加、NGS 技术的重大进步以及定序成本的大幅降低。此外，遗传疾病和癌症的盛行率不断增加，增加了对先进 NGS 检测的需求，推动了市场的成长。然而，这种增长受到了 NGS资料分析的复杂性、初始设置成本高以及缺乏熟练的生物资讯专业人员的挑战。人工智慧和机器学习的整合存在潜在的机会，可以简化资料分析，提高测序准确性，并开发创新的样品製备套件，以最大限度地减少劳动时间并最大限度地提高通量。对企业来说，投资与学术研究机构的联合研究为进一步创新打开了大门。追求样品製备的自动化可以显着减少人工错误和周转时间，这也是成长的途径。市场的限制包括严格的监管要求和围绕资料隐私的道德问题，这需要业界持续保持警惕。市场参与者应优先考虑微流体和合成生物学等领域的研发投资，这对于优化 NGS 流程至关重要。总体而言，NGS 样品製备市场的特点是快速的技术创新和动态的竞争格局，需要敏捷性和策略创新来利用新兴机会。

主要市场统计
基准年[2023] 48.9亿美元
预测年份 [2024] 56.3亿美元
预测年份 [2030] 130.9亿美元
复合年增长率（%） 15.08%

市场动态：快速发展的次世代定序仪样品製备市场的关键市场洞察

供需的动态交互作用正在改变次世代定序仪样品製备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • NGS 样品製备自动化的进展
    • 支持政府和私人组织进行大规模测序
    • 改进基于 NGS 的诊断测试的报销系统
  • 市场限制因素
    • 与 NGS 样本相关的伦理问题
  • 市场机会
    • 扩大NGS在农业的应用
    • 次世代定序仪样品製备的新技术进展
  • 市场挑战
    • 准确 NGS 样品製备的局限性

波特五力：引领次世代定序仪样品製备市场的策略工具

波特的五力框架是了解次世代定序仪样品製备市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对次世代定序仪样品製备市场的影响

外部宏观环境因素在塑造次世代定序仪样品製备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解次世代定序仪样品製备市场的竞争格局

对次世代定序仪样品製备市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵次世代定序仪样品製备市场供应商的绩效评估

FPNV定位矩阵是评估次世代定序仪样品製备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了次世代定序仪样品製备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，次世代定序仪定序样品製备市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 促进NGS样品製备的自动化
      • 支持政府和私人组织的大规模定序
      • 改进了基于 NGS 的诊断测试的报销概述
    • 抑制因素
      • 与 NGS 样本相关的伦理问题
    • 机会
      • 扩大NGS在农业的应用
      • 次世代定序仪样品製备的新技术进展
    • 任务
      • 准确 NGS 样品製备的局限性
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第 6 章次世代定序仪样品製备市场：依工作流程

  • 自动文库製备
  • 克隆扩增
  • NGS文库製备试剂套件
  • 半自动文库製备

第七章次世代定序仪样品製备市场：依应用分类

  • 农业基因组学与法医学
  • 临床调查
  • 消费者基因体学
  • HLA型检测/免疫系统监测
  • 总体基因体学、流行病学、药物开发
  • 肿瘤学
  • 生殖健康

第 8 章次世代定序仪样品製备市场：依最终用户分类

  • 学术研究
  • 临床调查
  • 医院/诊所
  • 製药和生物技术公司

第9章美洲次世代定序仪样品製备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章 亚太地区次世代定序仪样本製备市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的次世代定序仪样品製备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • BGI
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • Foundation Medicine, Inc.
  • Illumina, Inc.
  • Life Technologies Corp.
  • Macrogen, Inc.
  • Pacific Biosciences of California, Inc.
  • Perkin Elmer, Inc.
  • PierianDx, Inc.
  • Qiagen
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-2214614769A0

The Next-Generation Sequencing Sample Preparation Market was valued at USD 4.89 billion in 2023, expected to reach USD 5.63 billion in 2024, and is projected to grow at a CAGR of 15.08%, to USD 13.09 billion by 2030.

Next-Generation Sequencing (NGS) sample preparation is a critical component of the genomic sequencing process, entailing the conversion of native biological samples into a library of nucleic acids suitable for subsequent sequencing. This preparation is fundamental because effective sample processing ensures the accuracy and efficiency of the NGS techniques, widely utilized in genomic research, diagnostics, and personalized medicine. The market's end-use scope encompasses clinical diagnostics, pharmaceutical and biotechnology companies, academic research institutions, and agrigenomics, each leveraging NGS for diverse applications such as disease diagnosis, drug discovery, or crop improvement. Key growth drivers include the increasing demand for personalized medicine, significant advancements in NGS technologies, and a substantial reduction in sequencing costs. Additionally, the growing prevalence of genetic disorders and cancer has heightened the need for advanced NGS testing, fuelling market growth. However, this growth is met with challenges such as the complexity of the NGS data analysis, high initial setup costs, and a shortage of skilled professionals adept in bioinformatics. Potential opportunities lie in the integration of artificial intelligence and machine learning to streamline data analysis, improve sequencing accuracy, and develop innovative sample preparation kits that minimize hands-on time and maximize throughput. For businesses, investing in collaborations with academic and research institutions can pave the way for further innovation. Exploring automation in sample preparation can drastically reduce manual errors and time required, presenting another avenue for growth. Market limitations include stringent regulatory requirements and ethical concerns surrounding data privacy, demanding ongoing industry vigilance. To thrive, market players should prioritize R&D investment in areas like microfluidics and synthetic biology, crucial for optimizing NGS processes. Overall, the NGS sample preparation market is characterized by rapid technological advancements and a dynamic competitive landscape, necessitating agility and strategic innovation to capitalize on emerging opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 4.89 billion
Estimated Year [2024] USD 5.63 billion
Forecast Year [2030] USD 13.09 billion
CAGR (%) 15.08%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Next-Generation Sequencing Sample Preparation Market

The Next-Generation Sequencing Sample Preparation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing automation in NGS sample preparation
    • Government & private organizations support for large-scale sequencing
    • Improved reimbursement outline for NGS-based diagnostic tests
  • Market Restraints
    • Ethical concerns associated with NGS sample
  • Market Opportunities
    • Widening application of NGS in agriculture
    • New technological advancements in next-generation sequencing sample preparation
  • Market Challenges
    • Limitations in accurate NGS sample preparation

Porter's Five Forces: A Strategic Tool for Navigating the Next-Generation Sequencing Sample Preparation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Next-Generation Sequencing Sample Preparation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Next-Generation Sequencing Sample Preparation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Next-Generation Sequencing Sample Preparation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Next-Generation Sequencing Sample Preparation Market

A detailed market share analysis in the Next-Generation Sequencing Sample Preparation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Next-Generation Sequencing Sample Preparation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Next-Generation Sequencing Sample Preparation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Next-Generation Sequencing Sample Preparation Market

A strategic analysis of the Next-Generation Sequencing Sample Preparation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Sequencing Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BGI, Bio-Rad Laboratories, Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Foundation Medicine, Inc., Illumina, Inc., Life Technologies Corp., Macrogen, Inc., Pacific Biosciences of California, Inc., Perkin Elmer, Inc., PierianDx, Inc., Qiagen, Quest Diagnostics Incorporated, and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Sequencing Sample Preparation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Workflow, market is studied across Automated Library Preparation, Clonal Amplification, NGS Library Preparation Kits, and Semi-Automated Library Preparation.
  • Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing/Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health.
  • Based on End User, market is studied across Academic Research, Clinical Research, Hospitals & Clinics, and Pharma & Biotech Entities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing automation in NGS sample preparation
      • 5.1.1.2. Government & private organizations support for large-scale sequencing
      • 5.1.1.3. Improved reimbursement outline for NGS-based diagnostic tests
    • 5.1.2. Restraints
      • 5.1.2.1. Ethical concerns associated with NGS sample
    • 5.1.3. Opportunities
      • 5.1.3.1. Widening application of NGS in agriculture
      • 5.1.3.2. New technological advancements in next-generation sequencing sample preparation
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations in accurate NGS sample preparation
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Next-Generation Sequencing Sample Preparation Market, by Workflow

  • 6.1. Introduction
  • 6.2. Automated Library Preparation
  • 6.3. Clonal Amplification
  • 6.4. NGS Library Preparation Kits
  • 6.5. Semi-Automated Library Preparation

7. Next-Generation Sequencing Sample Preparation Market, by Application

  • 7.1. Introduction
  • 7.2. Agrigenomics & Forensics
  • 7.3. Clinical Investigation
  • 7.4. Consumer Genomics
  • 7.5. HLA Typing/Immune System Monitoring
  • 7.6. Metagenomics, Epidemiology & Drug Development
  • 7.7. Oncology
  • 7.8. Reproductive Health

8. Next-Generation Sequencing Sample Preparation Market, by End User

  • 8.1. Introduction
  • 8.2. Academic Research
  • 8.3. Clinical Research
  • 8.4. Hospitals & Clinics
  • 8.5. Pharma & Biotech Entities

9. Americas Next-Generation Sequencing Sample Preparation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Next-Generation Sequencing Sample Preparation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation Sequencing Sample Preparation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. BGI
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Eurofins Scientific SE
  • 5. F. Hoffmann-La Roche Ltd.
  • 6. Foundation Medicine, Inc.
  • 7. Illumina, Inc.
  • 8. Life Technologies Corp.
  • 9. Macrogen, Inc.
  • 10. Pacific Biosciences of California, Inc.
  • 11. Perkin Elmer, Inc.
  • 12. PierianDx, Inc.
  • 13. Qiagen
  • 14. Quest Diagnostics Incorporated
  • 15. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET DYNAMICS
  • TABLE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AUTOMATED LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLONAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS LIBRARY PREPARATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SEMI-AUTOMATED LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRIGENOMICS & FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL INVESTIGATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HLA TYPING/IMMUNE SYSTEM MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METAGENOMICS, EPIDEMIOLOGY & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REPRODUCTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMA & BIOTECH ENTITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 59. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 62. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 65. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 68. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 71. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 74. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 77. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 80. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 83. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 90. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 93. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 96. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 99. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 102. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 105. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 108. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 111. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 114. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 120. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 123. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 126. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 129. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 135. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 138. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 141. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 144. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 150. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 153. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2023